CoChat

Alkylating Agent–Induced NRF2 Blocks Endoplasmic Reticulum Stress–Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis

Open access
Zanotto-Filho, Alfeu, Masamsetti, V. Pragathi, Loranc, Eva, Tonapi, Sonal S., Gorthi, Aparna, Bernard, Xavier, Gonçalves, Rosângela Mayer, Moreira, José C.F., Chen, Yidong, Bishop, Alexander J.R. · 2016 · Molecular Cancer Therapeutics

Published version of a preprint

Cited by 68

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Alkylating agents are a commonly used cytotoxic class of anticancer drugs. Understanding the mechanisms whereby cells respond to these drugs is key to identify means to improve therapy while reducing toxicity. By integrating genome-wide gene expression profiling, protein analysis, and functional cell validation, we herein demonstrated a direct relationship between NRF2 and Endoplasmic Reticulum (ER) stress pathways in response to alkylating agents, which is coordinated by the availability of glutathione (GSH) pools. GSH is essential for both drug detoxification and protein thiol homeostasis within the ER, thus inhibiting ER stress induction and promoting survival, an effect independent of its antioxidant role. NRF2 accumulation induced by alkylating agents resulted in increased GSH synthesis via GCLC/GCLM enzyme, and interfering with this NRF2 response by either NRF2 knockdown or GCLC/GCLM inhibition with buthionine sulfoximine caused accumulation of damaged proteins within the ER, leading to PERK-dependent apoptosis. Conversely, upregulation of NRF2, through KEAP1 depletion or NRF2-myc overexpression, or increasing GSH levels with N-acetylcysteine or glutathione-ethyl-ester, decreased ER stress and abrogated alkylating agents–induced cell death. Based on these results, we identified a subset of lung and head-and-neck carcinomas with mutations in either KEAP1 or NRF2/NFE2L2 genes that correlate with NRF2 target overexpression and poor survival. In KEAP1-mutant cancer cells, NRF2 knockdown and GSH depletion increased cell sensitivity via ER stress induction in a mechanism specific to alkylating drugs. Overall, we show that the NRF2-GSH influence on ER homeostasis implicates defects in NRF2-GSH or ER stress machineries as affecting alkylating therapy toxicity. Mol Cancer Ther; 15(12); 3000–14. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1535-7163.mct-16-0271

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 59

  1. Hernandez-Aya, 2013, Adjuvant systemic therapies in breast cancer, Surg Clin North Am, 93, 473, 10.1016/j.suc.2012.12.002 · DOI
  2. Jones, 1993, Pharmacokinetic/pharmacodynamic interactions of intensive cyclophosphamide, cisplatin, and BCNU in patients with breast cancer, Breast Cancer Res Treat, 26, 7, 10.1007/BF00668355 · doi:10.1007/bf00668355
  3. Omuro, 2013, Glioblastoma and other malignant gliomas: A clinical review, JAMA, 310, 1842, 10.1001/jama.2013.280319 · DOI · Paper page
  4. Friedman, 2000, Temozolomide and treatment of malignant glioma, Clin Cancer Res, 6, 2585
  5. Chan, 2013, Chemotherapy advances in small-cell lung cancer, J Thorac Dis, 5, S565
  6. Lin, 2012, Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy, Free Radic Biol Med, 52, 377, 10.1016/j.freeradbiomed.2011.10.487 · DOI · Paper page
  7. Drablos, 2004, Alkylation damage in DNA and RNA–repair mechanisms and medical significance, DNA Repair (Amst), 3, 1389, 10.1016/j.dnarep.2004.05.004 · DOI · Paper page
  8. Malet-Martino, 1999, The analysis of cyclophosphamide and its metabolites, Curr Pharm Des, 5, 561, 10.2174/1381612805666230110214643 · doi:10.2174/1381612805666230110214643
  9. Altieri, 2008, DNA damage and repair: From molecular mechanisms to health implications, Antioxid Redox Signal, 10, 891, 10.1089/ars.2007.1830 · DOI · Paper page
  10. Workman, 2006, A systems approach to mapping DNA damage response pathways, Science, 312, 1054, 10.1126/science.1122088 · DOI · Paper page
  11. Jaramillo, 2013, The emerging role of the Nrf2-Keap1 signaling pathway in cancer, Genes Dev, 27, 2179, 10.1101/gad.225680.113 · DOI · Paper page
  12. Li, 2012, Mechanism of chemical activation of Nrf2, PLoS One, 7, e35122, 10.1371/journal.pone.0035122 · DOI · Paper page
  13. Moore, 1991, Clinical pharmacokinetics of cyclophosphamide, Clin Pharmacokinet, 20, 194, 10.2165/00003088-199120030-00002 · doi:10.2165/00003088-199120030-00002
  14. Lin, 2009, Divergent effects of PERK and IRE1 signaling on cell viability, PLoS One, 4, e4170, 10.1371/journal.pone.0004170 · DOI · Paper page
  15. Novoa, 2001, Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha, J Cell Biol, 153, 1011, 10.1083/jcb.153.5.1011 · DOI · Paper page
  16. Lin, 2007, IRE1 signaling affects cell fate during the unfolded protein response, Science, 318, 944, 10.1126/science.1146361 · DOI · Paper page
  17. Ma, 2003, Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress, J Biol Chem, 278, 34864, 10.1074/jbc.M301107200 · DOI · Paper page
  18. Birk, 2013, Endoplasmic reticulum: Reduced and oxidized glutathione revisited, J Cell Sci, 126, 1604
  19. Raturi, 2007, Characterization of redox state and reductase activity of protein disulfide isomerase under different redox environments using a sensitive fluorescent assay, Free Radic Biol Med, 43, 62, 10.1016/j.freeradbiomed.2007.03.025 · DOI
  20. Chakravarthi, 2006, The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress, EMBO Rep, 7, 271, 10.1038/sj.embor.7400645 · DOI · Paper page
  21. Zanotto-Filho, 2016, Combined gene expression and RNAi screening to identify alkylation damage survival pathways from fly to human, PLoS One, 11, e0153970, 10.1371/journal.pone.0153970 · DOI
  22. Nikolova, 2010, Homologous recombination protects mammalian cells from replication-associated DNA double-strand breaks arising in response to methyl methanesulfonate, DNA Repair (Amst), 9, 1050, 10.1016/j.dnarep.2010.07.005 · DOI
  23. Zanotto-Filho, 2010, The pharmacological NFkappaB inhibitors BAY117082 and MG132 induce cell arrest and apoptosis in leukemia cells through ROS-mitochondria pathway activation, Cancer Lett, 288, 192, 10.1016/j.canlet.2009.06.038 · DOI
  24. Cox, 2007, High throughput method for assessment of cellular reduced glutathione in mammalian cells, J Environ Prot Sci, 1, 23
  25. Kim, 1995, Dibromobimane as a fluorescent crosslinking reagent, Anal Biochem, 225, 174, 10.1006/abio.1995.1131 · DOI
  26. Furukawa, 2005, BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase, Mol Cell Biol, 25, 162, 10.1128/MCB.25.1.162-171.2005 · DOI · Paper page
  27. Aguirre-Gamboa, 2013, SurvExpress: An online biomarker validation tool and database for cancer gene expression data using survival analysis, PLoS One, 8, e74250, 10.1371/journal.pone.0074250 · DOI · Paper page
  28. Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, 6, pl1, 10.1126/scisignal.2004088 · DOI · Paper page
  29. Cerami, 2012, The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 · DOI · Paper page
  30. Komiya, 1998, Role of glutathione in cisplatin resistance in osteosarcoma cell lines, J Orthop Res, 16, 15, 10.1002/jor.1100160104 · DOI
  31. Koharyova, 2015, Thioredoxin system - a novel therapeutic target, Gen Physiol Biophys, 34, 221, 10.4149/gpb_2015006 · DOI
  32. Cullinan, 2003, Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival, Mol Cell Biol, 23, 7198, 10.1128/MCB.23.20.7198-7209.2003 · DOI · Paper page
  33. Li, 2008, The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells, Cell Death Differ, 15, 1460, 10.1038/cdd.2008.81 · DOI · Paper page
  34. Ohta, 2008, Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth, Cancer Res, 68, 1303, 10.1158/0008-5472.CAN-07-5003 · DOI · Paper page
  35. Canning, 2015, Structural basis of Keap1 interactions with Nrf2, Free Radic Biol Med, 88, 101, 10.1016/j.freeradbiomed.2015.05.034 · DOI · Paper page
  36. Abazeed, 2013, Integrative radiogenomic profiling of squamous cell lung cancer, Cancer Res, 73, 6289, 10.1158/0008-5472.CAN-13-1616 · DOI · Paper page
  37. Sharp, 1998, Lack of a role for MRP1 in platinum drug resistance in human ovarian cancer cell lines, Br J Cancer, 78, 175, 10.1038/bjc.1998.461 · DOI
  38. Wen, 2014, Transgenic expression of the human MRP2 transporter reduces cisplatin accumulation and nephrotoxicity in Mrp2-null mice, Am J Pathol, 184, 1299, 10.1016/j.ajpath.2014.01.025 · DOI
  39. Syu, 2016, Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia, Oncotarget, 7, 14659, 10.18632/oncotarget.7406 · DOI · Paper page
  40. Tsai-Turton, 2007, Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion, Toxicol Sci, 98, 216, 10.1093/toxsci/kfm087 · DOI · Paper page
  41. Gurgen, 2013, Chemoprotective effect of ascorbic acid, alpha-tocopherol, and selenium on cyclophosphamide-induced toxicity in the rat ovarium, Nutrition, 29, 777, 10.1016/j.nut.2012.11.004 · doi:10.1016/j.nut.2012.11.004
  42. Cuce, 2015, Chemoprotective effect of vitamin E in cyclophosphamide-induced hepatotoxicity in rats, Chem Biol Interact, 232, 7, 10.1016/j.cbi.2015.02.016 · doi:10.1016/j.cbi.2015.02.016
  43. Gross, 2004, Structure of Ero1p, source of disulfide bonds for oxidative protein folding in the cell, Cell, 117, 601, 10.1016/S0092-8674(04)00418-0 · DOI · Paper page
  44. Zhang, 2005, Differential adduction of proteins vs. deoxynucleosides by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro, Rapid Commun Mass Spectrom, 19, 438, 10.1002/rcm.1806 · doi:10.1002/rcm.1806
  45. Paik, 1984, Alkylation of protein by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro, Cancer Lett, 23, 9, 10.1016/0304-3835(84)90056-9 · doi:10.1016/0304-3835(84)90056-9
  46. Trezl, 1987, Studies on in vitro S-methylation of naturally occurring thiol compounds with N-methyl-N-nitrosourea and methyl methanesulfonate, Environ Res, 43, 417, 10.1016/S0013-9351(87)80042-7 · doi:10.1016/s0013-9351(87)80042-7
  47. Karasawa, 2013, Identification of cisplatin-binding proteins using agarose conjugates of platinum compounds, PLoS One, 8, e66220, 10.1371/journal.pone.0066220 · DOI
  48. Shi, 2016, ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells, Oncol Rep, 35, 2606, 10.3892/or.2016.4680 · DOI
  49. Xu, 2015, Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis, Oncol Rep, 34, 3051, 10.3892/or.2015.4283 · DOI
  50. Rabik, 2008, Enhancement of cisplatin [cis-diammine dichloroplatinum (II)] cytotoxicity by O6-benzylguanine involves endoplasmic reticulum stress, J Pharmacol Exp Ther, 327, 442, 10.1124/jpet.108.141291 · DOI
  51. Jiang, 2009, Glucose-regulated protein 78 antagonizes cisplatin and adriamycin in human melanoma cells, Carcinogenesis, 30, 197, 10.1093/carcin/bgn220 · DOI
  52. Li, 2014, Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78, Oncol Rep, 31, 2525, 10.3892/or.2014.3147 · DOI
  53. Rocha, 2014, Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo, Cell Death Dis, 5, e1505, 10.1038/cddis.2014.465 · DOI · Paper page
  54. Ma, 2015, p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ, Med Oncol, 32, 69, 10.1007/s12032-015-0517-y · DOI
  55. Zanotto-Filho, 2015, Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas, Cancer Lett, 358, 220, 10.1016/j.canlet.2014.12.044 · DOI · Paper page
  56. Wang, 2006, Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents, Cancer Res, 66, 10983, 10.1158/0008-5472.CAN-06-2298 · DOI · Paper page
  57. Shibata, 2008, Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer, Gastroenterology, 135, 1358, 10.1053/j.gastro.2008.06.082 · DOI · Paper page
  58. Homma, 2009, Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer, Clin Cancer Res, 15, 3423, 10.1158/1078-0432.CCR-08-2822 · DOI · Paper page
  59. Singh, 2008, RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy, Cancer Res, 68, 7975, 10.1158/0008-5472.CAN-08-1401 · DOI · Paper page

Cited by

See all 68

Metadata

Authors
Zanotto-Filho, A., Masamsetti, V. P., Loranc, E., Tonapi, S. S., Gorthi, A., Bernard, X., Gonçalves, R. M., Moreira, J. C. F., Chen, Y., & Bishop, A. J. R.
Venue
Molecular Cancer Therapeutics
Published
2016-12-01
Volume
15
Issue
12
Pages
3000-3014
ISSN
  • 1535-7163 (ISSN-L)
  • 1538-8514
OpenAlex
W2519151861
Cited by
68
References
4
FWCI
2.86
Type
journal article
Language
en
Open access
green
Funders
  • NIH (K22ES012264, 1R15ES019128, and 1R01CA152063, CA054174)
  • DOD CDMRP (W81XWH-14-1-0026)
  • MCTI National Tax Service (485758/13-0)
  • NCI (5T32CA148724)
  • CPRIT (RP101491)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alkylating Agent–Induced NRF2 Blocks Endoplasmic Reticulum Stress–Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis. https://app.cochat.ai/papers/10.1158/1535-7163.mct-16-0271
The paper
Zanotto-Filho, A., Masamsetti, V. P., Loranc, E., Tonapi, S. S., Gorthi, A., Bernard, X., Gonçalves, R. M., Moreira, J. C. F., Chen, Y., & Bishop, A. J. R. (2016). Alkylating Agent–Induced NRF2 Blocks Endoplasmic Reticulum Stress–Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-16-0271

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.